Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4118-4122

  Nakanishi, Takeo ^a   Tamai, Ikumi ^a   Sai, Yoshimichi ^a   Sasaki, Takuma ^a   Tsuji, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACTIVE TRANSPORT; ARTICLE; DRUG TRANSPORT; DRUG UPTAKE; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT; TARGET CELL;

BIOLOGICAL TRANSPORT; FIBROBLASTS; FIBROSARCOMA; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 0030805221     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Halvor, N. C. and Marie, L. An amino acid transport system of unassigned function in the Ehrlich ascites tumor cell. J. Biol. Chem., 240: 3601-3607, 1965.
2. Belt, J. A., Marina, N. M, Phelps, D. A., and Crawford, C. R. Nucleoside transporter in normal and neoplastic cells. Adv. Enzyme Regul., 33: 235-252, 1993.
3. Brown, R. S., and Wahl, R. L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohisiochemical study. Cancer (Phila.), 72: 2979-2985, 1993.
4. Goldman, I. D., Liechtenstein, N. S., and Oliverio, V. T. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J. Biol. Chem., 243: 5007-5017, 1968.
5. Vistica, D. T., and Rabinovitz, M. Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system. Biochem. Biophys. Res. Commun., 14: 929-932, 1979.
6. Vistica, D. T. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. Biochim. Biophys. Acta. 550: 309-317, 1979.
7. Pohl, J., Bertram, B., Hilgard, P., Nowrousian, M. R. Stuben, J., and Wiessler, M. D-19575: a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother. Pharmacol., 35: 364-370, 1995.
8. Sirotnak, F. M., and Donsbach, R. C. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia. Cancer Res., 33: 1290-1294, 1973.
9. Goldman, I. D. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells. Biochim. Biophys. Acta, 233: 624-634, 1971.
10. Fei, Y. J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., and Hediger, M. A. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature (Lond.), 368: 563-566, 1994.
11. +/peptide cotransporter. J. Biol. Chem., 270: 6456-6463, 1995.
12. +/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. J. Pharmacol. Exp. Ther., 275, 1631-1637, 1995.
13. Miyamoto, K., Shiraga, T., Morita, K., Yamamoto, H., Haga, H., Taketani, Y., Tamai, I., Sai, Y., Tsuji, A., and Takeda, E. Sequence, tissue distribution and developmental change in rat intestinal oligopeptide transporter. Biochim. Biophys. Acta, 1305: 34-38, 1996.
14. +/peptide cotransporter family, from human kidney. Biochim. Biophys. Acta, 1235: 461-466, 1995.
15. Saito, H., Terada, T., Okuda, M., Sasaki, S., and Inui, K. Molecular cloning and tissue distribution of rat peptide transporter. Biochim. Biophys. Acta, 1280: 173-177, 1996.
16. Sai, Y., Tamai, I., Sumikawa, H., Hayashi, K., Nakanishi, T., Amano, O., Numata, M., Iseki, S., and Tsuji, A. Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of β-lactam antibiotics. FEBS Lett., 392: 25-29, 1996.
17. Suraiya, R., Walter, A., Nelson, R., Eva, M. T., Paul, A., and Murray, B. G. Characterization of a newly derived human sarcoma cell line (HT1080). Cancer (Phila.), 33: 1027-1033, 1974.
18. Nichols, W. W., Murphy, D. G., Cristofald, V. J., Toji, L. H., Green, A. E., and Dwight, S. A. Characterization of a new human diploid cell strain. IMR-90. Science (Washington DC), 196: 60-63, 1971.
19. Pinto, M., Robine, L. S., Appay, M. D., Kedinger, M., Triadou, N., Dussaulx, I., Lacroix, B., Simon, A. P., Haffen, K., Fogh, J., and Zweibaum, A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell, 47: 323-330, 1982.
20. Mullin, J. M., Weibel, J., Diamond, L., and Kleinzeller, A. Sugar transport in the LLC-PK1 renal epithelial cell line: similarity to mammalian kidney and the influence of cell density. J. Cell. Physiol., 104: 375-389, 1980.
21. Tsuji, A., Takanaga, H., Tamai, I., and Terasaki, T. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res., 11: 30-37, 1994.
22. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
23. Yamaoka, K., Tanigawara, Y., Nakagawa, T., and Uno, T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn., 4: 879-885, 1981.
24. Tamai, I., Tomizawa, N., Kadowaki, A., Terasaki, T., Nakayama, K., Higashida, H., and Tsuji, A. Functional expression of intestinal dipeptide/β-lactam antibiotic transporter in Xenopus laevis oocytes. Biochem. Pharmacol., 48: 881-888, 1994.
25. Tamai, I., Nakanishi, T., Hayashi, K., Terao, T., Sai, Y., Shiraga., T., Miyamoto, K., Takeda, E., Higashida, H., and Tsuji, A. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of β-lactam antibiotics in the rat small intestine. J. Pharm. Pharmacol., in press, 1997.
26. Ganapathy, M. E., Brandsch, M., Prasad, P. D., Ganapathy, V., and Leibach, F. H. Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters. PepT1 and PepT2. J. Biol. Chem., 270: 25672-25677, 1995.
27. Tsuji, A., and Tamai, I. Carrier-mediated intestinal transport of drugs. Pharm. Res., 13: 963-977, 1996.
28. Taylor, M. D., and Amidon, G. L. Peptide-based drug design, In: A. Tsuji (ed.), Intestinal Absorption of β-Lactam Antibiotics, pp. 101-134. Washington, DC: American Chemical Society, 1995.
29. Dantzig, A. H., and Bergin, L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta, 1027: 211-217, 1990.
30. Dantzig, A. H., and Bergin, L. Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun., 155, 1082-1087, 1988.
31. Wilson, D., Barry, J. A., and Ramaswamy, K. Characteristics of tripeptide transport in human jejunal brush-border membrane vesicles. Biochim. Biophys. Acta, 986: 123-129, 1989.
32. 125I-labeled tyrosyl peptides as substrates. Biochim. Biophys. Acta, 1069: 14-20, 1991.
33. Saito, H., and Inui, K. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265: G289-G294, 1993.
34. + gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brushborder membrane vesicles from rat small intestine. J. Pharmacol. Exp. Ther., 241: 594-601, 1987.
35. Tamai, I., Tomizawa, N., Takeuchi, T., Nakayama, K., Higashida, H., and Tsuji, A. Functional expression of transporter for β-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestine. J. Pharmacol. Exp. Ther., 237: 26-31, 1995.
36. Ramamoorthy, S., Liu, W., Ma, Y. Y., Yang, Feng, T. L., Ganapathy, V., and Leibach, F. H. Proton/peptide cotransporter (PepT2) from human kidney: functional characterization and chromosomal localization. Biochim. Biophys. Acta, 1240: 1-4, 1995.